Results 181 to 190 of about 33,449 (240)

Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century. [PDF]

open access: yesBJPsych Open
Bender DA   +33 more
europepmc   +1 more source

OctoChemDB: An Aggregated Database for Small Molecule Identification Using High-Resolution MS Data. [PDF]

open access: yesAnal Chem
Silvestre R   +6 more
europepmc   +1 more source

Review of Selected 2-Phenylethylamine Derivatives and Opioids, Systematic Review of Their Effects on Psychomotor Abilities and Driving Performance: Psychopharmacology in the Context of Road Safety. [PDF]

open access: yesPharmaceuticals (Basel)
Żełabowski K   +11 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

MDMA (Ecstasy)

Annals of Clinical Psychiatry, 2007
3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy) is a synthetic amphetamine analogue that is recreationally used to obtain a psychological effect of enhanced affiliative emotional response. Its use in Western countries appears to be increasing, particularly among young individuals.Pertinent basic and clinical literature is critically reviewed.A ...
Rif S, El-Mallakh, Henry David, Abraham
openaire   +2 more sources

MDMA

2023
Abstract MDMA (3,4-methylenedioxymethamphetamine) was originally synthesized and patented by the Merck chemical company in 1914. It was not explored for human use until the 1970–80s when there were published reports that it could be a useful catalyst to psychotherapy, in part because it often produced reduced anxiety and increased ...
Michael C. Mithoefer, David E. Presti
openaire   +1 more source

MDMA and MDMA-Assisted Therapy

American Journal of Psychiatry
MDMA (i.e., 3,4-methylenedixoymethamphetamine), commonly known as "Ecstasy" or "Molly," has been used since the 1970s both in recreational and therapeutic settings. The Food and Drug Administration (FDA) designated MDMA-Assisted Therapy (MDMA-AT) as a Breakthrough Therapy for posttraumatic stress disorder (PTSD) in 2017, and the FDA is requiring an ...
Aaron S, Wolfgang   +9 more
openaire   +2 more sources

Dosing Psychedelics and MDMA

2021
Classic psychedelics, including psilocybin, lysergic acid diethylamide (LSD), dimethyltryptamine, and mescaline, and entactogens/empathogens, especially 3,4-methylenedioxymethamphetamine, have received renewed attention in psychiatric research and may be developed into medications for such indications as anxiety, depression, cluster headache, and ...
Liechti, Matthias E., Holze, Friederike
openaire   +3 more sources

Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

Pediatric Emergency Care, 2000
Ecstasy (MDMA) is an amphetamine derivative of growing popularity. The drug produces a range of toxicities when taken either in standard doses or overdose. In overdose it has major toxicity, producing several different life-threatening manifestations. Hepatotoxicity and hyponatremia are common but poorly understood consequences of MDMA overdose.
openaire   +2 more sources

Home - About - Disclaimer - Privacy